Supplements

Lab Tests for IBS: What Your Results Actually Mean

IBS affects roughly 10–15% of adults worldwide, yet most people leave their doctor's office with a symptom-based diagnosis and no biological explanation. Strategic lab testing changes that picture entirely — it shifts the conversation from 'you have IBS' to 'here is exactly what is driving your symptoms and what you can do about it.'

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·10 min read
IBSSIBOleaky gutgut healthlab testingfunctional medicine
Lab Tests for IBS: What Your Results Actually Mean

Lab Tests for IBS: What Your Results Actually Mean

Irritable bowel syndrome (IBS) is one of the most diagnosed and least understood GI conditions in modern medicine. The Rome IV criteria define it by symptom clusters — cramping, bloating, altered bowel habits — without requiring a biological marker. That means most people get a clinical diagnosis without ever understanding why their gut is behaving the way it is.

That's where strategic lab testing changes the picture. A well-chosen panel doesn't just confirm IBS; it reveals the specific physiological disruptions driving your symptoms. Understanding which lab tests for IBS are worth ordering — and what the results actually mean — is the first step toward a targeted recovery plan rather than a rotating carousel of elimination diets and over-the-counter remedies.

---

Why Standard IBS Diagnostics Often Fall Short

Conventional IBS workups typically include a complete blood count (CBC), basic metabolic panel, C-reactive protein (CRP), thyroid-stimulating hormone (TSH), and sometimes a fecal calprotectin to rule out inflammatory bowel disease. These tests are good at ruling things out, but they rarely pinpoint functional drivers.

Research published in Gut found that IBS patients show distinct alterations in gut microbiome composition, intestinal barrier integrity, visceral sensitivity, and even immune activation — none of which a standard CBC will capture (Simrén et al., Gut 2013; PMID: 22180058). Meanwhile, up to 84% of IBS-D (diarrhea-predominant) patients may have concurrent small intestinal bacterial overgrowth (SIBO), according to a meta-analysis in the American Journal of Gastroenterology (Ford et al., Am J Gastroenterol 2009; PMID: 19536097).

The functional medicine and integrative GI communities have responded by developing expanded diagnostic frameworks. Here's a breakdown of the most evidence-supported lab tests for IBS, organized by what they target.

---

Core Lab Tests for IBS Worth Ordering

1. Comprehensive Stool Analysis

A comprehensive stool panel (such as GI-MAP or similar PCR-based stool tests) measures pathogenic bacteria, beneficial flora ratios, intestinal immune markers (sIgA), zonulin, calprotectin, and markers of digestion like pancreatic elastase-1. Low elastase-1 — typically below 200 µg/g stool — suggests exocrine pancreatic insufficiency (EPI), which commonly presents with IBS-like bloating, steatorrhea, and diarrhea. EPI is frequently missed because it doesn't manifest on a standard lipid panel or liver enzyme test.

Fecal calprotectin is a particularly useful triage marker. A 2010 meta-analysis of 13 studies found calprotectin had a pooled sensitivity of 93% and specificity of 96% for distinguishing IBD from IBS, sparing patients unnecessary colonoscopies (van Rheenen et al., BMJ 2010; PMID: 20200057). If calprotectin comes back elevated (>50 µg/g), the working diagnosis of IBS should be reconsidered and referred for colonoscopy. If it's normal, that result itself guides the clinician toward functional rather than structural pathology.

Secretory IgA (sIgA) in stool is another frequently overlooked marker. Low sIgA reflects mucosal immune suppression — often driven by chronic stress or HPA-axis dysregulation — and is associated with increased susceptibility to opportunistic pathogens and poor gut flora stability.

2. Hydrogen/Methane Breath Test (SIBO)

This is the front-line test for SIBO, one of the most common underlying causes of IBS symptoms. More on this in the dedicated section below.

3. Intestinal Permeability Markers

Zonulin (blood or stool), Lipopolysaccharide (LPS) antibodies, and occludin/claudin antibodies can all flag a compromised gut lining — sometimes called "leaky gut" in lay terms, or intestinal hyperpermeability in clinical literature. Elevated serum zonulin correlates with both IBS and systemic low-grade inflammation. A 2012 study in Gut demonstrated that IBS-D patients had significantly elevated zonulin levels compared to healthy controls, and those levels correlated with the degree of gut permeability as measured by the lactulose/mannitol urine ratio (Piche et al., Gut 2009; PMID: 19136509).

4. Food Sensitivity and Immune Panels

IgG food antibody panels (Cyrex Array 10 or similar) remain controversial in conventional gastroenterology but are widely used in functional GI medicine. The mechanism is distinct from IgE-mediated food allergy: IgG reactions are delayed (up to 72 hours), making them nearly impossible to identify without testing. While large-scale RCT data is limited, a 2004 RCT published in Gut found that an elimination diet guided by IgG testing led to a 26% reduction in IBS symptom scores versus a sham diet, with a 39% reduction in patients who strictly adhered to the elimination protocol (Atkinson et al., Gut 2004; PMID: 15306607).

5. Organic Acids Test (OAT)

The OAT measures byproducts of microbial metabolism in urine and can identify yeast overgrowth (elevated arabinose), bacterial dysbiosis markers (elevated HPHPA from Clostridia), and mitochondrial pathway dysfunction. It's not a first-line IBS test, but in patients with fatigue accompanying GI symptoms, the OAT often reveals a broader metabolic picture that explains treatment resistance.

---

Lab Tests for SIBO: Breath Testing Protocols Explained

SIBO testing has become more sophisticated over the past decade. The standard lactulose or glucose hydrogen breath test measures hydrogen and methane gas produced when gut bacteria ferment the substrate. The 2017 North American Consensus updated diagnostic criteria: a rise of ≥20 ppm hydrogen above baseline within 90 minutes on lactulose, or ≥12 ppm on glucose, is considered a positive SIBO result (Rezaie et al., Am J Gastroenterol 2017; PMID: 28323273).

Methane-dominant SIBO (now reclassified as intestinal methanogen overgrowth, or IMO) is associated with IBS-C (constipation-predominant IBS). Methane gas itself directly slows intestinal transit by acting on smooth muscle. A methane level ≥10 ppm at any point in the test is considered positive for IMO. This distinction matters clinically: hydrogen-dominant SIBO often responds to rifaximin alone, whereas IMO typically requires rifaximin plus neomycin or high-dose allicin.

A third gas — hydrogen sulfide — is produced by sulfate-reducing bacteria and is associated with IBS-D and a "rotten egg" smell to flatulence. Standard breath tests do not measure H2S, though newer three-gas devices are emerging. If a patient tests negative on standard breath testing yet has classic IBS-D symptoms, H2S SIBO should be on the differential.

For clinicians ordering these tests, it's worth noting that proton pump inhibitors (PPIs), antibiotics within 4 weeks, and certain probiotics can all produce false negatives on breath testing. A proper two-week washout is recommended before testing.

---

Lab Tests for Leaky Gut: Beyond Zonulin

The term "leaky gut" gets used loosely, but intestinal permeability is a measurable, documented phenomenon. The two most rigorous ways to assess it are:

1. Lactulose/Mannitol Urine Test: The patient ingests a measured solution of lactulose (a large sugar) and mannitol (a small sugar). In a healthy gut, mannitol absorbs easily while lactulose does not. An elevated lactulose-to-mannitol ratio in urine collected over 6 hours indicates paracellular permeability — gaps in the tight junction barrier. This test has been used in multiple clinical trials and is considered the gold standard for research settings.

2. Serum Zonulin-1 (Haptoglobin-2 Precursor): Elevated circulating zonulin is now a validated biomarker of tight junction disruption. Elevated levels have been reported in celiac disease, type 1 diabetes, and IBS. Note that most commercially available zonulin assays actually measure haptoglobin precursors, not zonulin itself — a distinction that matters when interpreting borderline results.

3. LPS-Binding Protein (LBP): When gram-negative bacteria translocate across a leaky epithelium, their lipopolysaccharide (LPS) coat triggers an immune response. LBP is an acute-phase protein that rises in response to circulating LPS. Elevated LBP in the absence of overt infection is a compelling signal of gut barrier dysfunction driving systemic low-grade inflammation — a pattern increasingly linked to metabolic disease as well as GI symptoms.

If you're managing cholesterol alongside gut symptoms, understanding how total cholesterol connects to inflammation can help you see how gut barrier dysfunction fits into a broader metabolic picture.

---

Lab Tests for Hormonal Acne: The Gut-Skin Axis Connection

If you're running an IBS workup and also dealing with persistent acne, testing the gut-skin axis may be worth discussing with your provider. The connection is mechanistic, not speculative. Gut dysbiosis and intestinal hyperpermeability increase systemic LPS burden, which elevates inflammatory cytokines (IL-1β, TNF-α) that directly promote sebaceous gland activity and keratinocyte proliferation — the cellular events behind inflammatory acne.

Hormonal acne specifically implicates androgens. Relevant lab markers in this context include:

MarkerWhat It RevealsReference Range (Females)
Total & Free TestosteroneDirect androgen burdenFree T < 2.2 pg/mL
DHEA-SAdrenal androgen production35–430 µg/dL (age-dependent)
SHBGProtein binding free androgens18–144 nmol/L
Fasting InsulinInsulin drives androgen synthesis< 7 µIU/mL fasting
Estradiol / Progesterone RatioEstrogen dominance patternVaries by cycle phase

Elevated fasting insulin is a particularly important finding. Insulin stimulates ovarian theca cells to produce testosterone and suppresses hepatic SHBG synthesis — a double mechanism that increases free androgen availability. The gut-insulin connection is direct: dysbiosis-driven LPS translocation activates TLR4 receptors in adipose tissue and the liver, impairing insulin signaling. This means that labs for IBS and labs for hormonal acne often point to the same upstream problem: a disrupted gut microbiome feeding systemic inflammation.

If your A1C or fasting glucose is creeping upward alongside gut symptoms, reviewing what supplements affect A1C gives useful context on the metabolic overlap.

---

Lab Tests for Mitochondrial Health: When Fatigue Accompanies IBS

Fatigue is a commonly underreported IBS comorbidity. When patients describe profound, disproportionate exhaustion alongside gut symptoms, mitochondrial dysfunction enters the differential. The gut is an extremely high energy-demand tissue — enterocytes turn over every 3–5 days and require robust ATP production to maintain tight junctions, mucus secretion, and immune surveillance.

The following labs provide indirect but clinically useful windows into mitochondrial function:

TestWhat It MeasuresClinical Significance
Lactate / Pyruvate RatioMitochondrial electron transport efficiencyRatio >20 suggests impaired oxidative phosphorylation
Organic Acids (OAT)Krebs cycle intermediates, CoQ10 sufficiency markersElevated succinate or fumarate suggests Complex II dysfunction
CoQ10 (Plasma Ubiquinol)Electron transport chain cofactorOptimal: 0.8–1.0 µg/mL; deficiency common in statin users
Carnitine (Free & Acyl)Fatty acid transport into mitochondriaLow free carnitine impairs β-oxidation
RBC MagnesiumMg²⁺ is a cofactor for 300+ enzymatic reactions including ATP synthaseSerum Mg poorly reflects intracellular status

Mitochondrial function and cholesterol metabolism are intertwined — statins inhibit both HMG-CoA reductase and endogenous CoQ10 synthesis, which explains why some statin users develop fatigue and GI dysmotility as a side effect. If your cholesterol panel is part of this workup, reviewing how to lower LDL without medication may help you weigh options that don't carry the CoQ10 depletion risk.

---

A Practical IBS Lab Protocol: What to Order and in What Order

Not every test belongs in a first-line workup. Here's a tiered approach based on clinical rationale:

Tier 1 — Order First (Triage and Rule-Out)

  1. CBC with differential
  2. CRP + ESR (inflammation screen)
  3. Fecal calprotectin (IBD vs. IBS)
  4. TSH + Free T4 (thyroid as IBS mimic)
  5. Celiac antibodies (tTG-IgA + total IgA)
  6. Fasting glucose + fasting insulin

Tier 2 — Order After Tier 1 is Reviewed

  1. Lactulose or glucose hydrogen/methane breath test (SIBO/IMO)
  2. Comprehensive stool analysis (pathogen, flora, calprotectin, elastase-1, sIgA)
  3. Serum zonulin or LBP (leaky gut markers)
  4. IgG food panel (if elimination diet has failed)

Tier 3 — Add If Fatigue, Acne, or Metabolic Symptoms Are Present

  1. Full hormone panel (testosterone, DHEA-S, SHBG, estradiol, progesterone)
  2. Organic Acids Test (OAT)
  3. RBC magnesium + plasma CoQ10
  4. Carnitine (free and acyl)

This tiered approach prevents the common mistake of ordering everything at once, generating overwhelming data, and creating an interpretive bottleneck. Begin with the highest-yield, lowest-cost tests and use those results to guide what comes next.

---

What This Means for Your Formula

Ones is designed to respond to the kind of data a comprehensive IBS lab panel generates, not generic complaints. When your blood work, stool markers, and health history are analyzed together, the AI health practitioner identifies patterns — low sIgA with elevated zonulin, methane-dominant SIBO with constipation, mitochondrial markers pointing to CoQ10 insufficiency — and builds a custom capsule formula calibrated to those specific findings.

For IBS presentations with elevated inflammatory markers and evidence of gut barrier compromise, Ones' Liver Support system blend becomes relevant: a disrupted gut-liver axis means endotoxins entering portal circulation place additional burden on hepatic detoxification. When fatigue and CoQ10-related markers are flagged, Ones includes CoQ10 as Ubiquinol at 200mg — the reduced, more bioavailable form, dosed at the level used in clinical mitochondrial support trials. For adrenal involvement (low sIgA, elevated cortisol metabolites), the Adrenal Support blend addresses HPA-axis modulation, which in turn supports mucosal immune function.

The principle is the same throughout: the formula follows the data, not a default protocol. That's the difference between a personalized plan and a generic gut supplement stack.

If thyroid markers are part of your broader workup — which they should be, since hypothyroidism frequently masquerades as IBS-C — reviewing what supplements affect thyroid antibodies provides useful background before interpreting your TSH and Free T4 results alongside your GI data.

---

Key Takeaways

  • Standard IBS diagnostics rule out serious pathology but rarely identify functional drivers; expanded testing is needed to personalize treatment.
  • SIBO breath testing (lactulose or glucose, measuring hydrogen and methane) identifies a treatable cause in up to 84% of IBS-D cases — but requires proper preparation to avoid false negatives.
  • Intestinal permeability markers (zonulin, LBP, lactulose/mannitol urine test) can confirm gut barrier dysfunction driving systemic inflammation, hormonal disruption, and metabolic changes.
  • Lab tests for hormonal acne and IBS share common upstream markers — fasting insulin, SHBG, and stool-derived LPS burden — making a combined panel more efficient than separate workups.
  • Mitochondrial markers (CoQ10, RBC magnesium, organic acids, carnitine) explain why fatigue accompanies IBS in a significant subset of patients and guide targeted supplementation.
  • A tiered lab approach — triage first, functional second, metabolic third — prevents data overload and ensures each result informs the next decision.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading